REDWOOD CITY, Calif.,
April 24, 2017 /PRNewswire/ -- Nevro
Corp. (NYSE: NVRO), a global medical device company that is
providing innovative evidence-based solutions for the treatment of
chronic pain, today announced that it will release financial
results for the first quarter of 2017 after market close on
Monday, May 8, 2017. Company
management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Monday, May 8, 2017.
Investors interested in listening to the conference call may do
so by dialing (877) 201-0168 for U.S. callers, or (647) 788-4901
for international callers (Conference ID: 6073641), or from the
webcast on the "Investors" section of the Company's website at
www.nevro.com/investors. Following the call, a replay will be
available on the Investor Events and Presentations webpage of the
Company's website.
About Nevro
Headquartered in Redwood City, California, Nevro is a global
medical device company focused on providing innovative products
that improve the quality of life of patients suffering from
debilitating chronic pain. Nevro has developed and commercialized
the Senza spinal cord stimulation (SCS) system, an evidence-based
neuromodulation platform for the treatment of chronic pain. The
Senza system is the only SCS system that delivers Nevro's
proprietary HF10 therapy. Senza, HF10, Nevro and the Nevro logo are
trademarks of Nevro.
Investor Relations Contact:
Nevro Investor
Relations
Katherine Bock
(650) 433-3247
ir@nevro.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nevro-to-report-operating-results-for-the-first-quarter-2017-300444316.html
SOURCE Nevro Corp.